7 Investment Premises That Crushed the Market in Q3 2025

ML
Matt Lusto
| October 28, 2025 | 15 min read

Every quarter, we analyze the premises our users explore and track how the identified stocks perform. Q3 2025 was remarkable—several theses significantly outperformed broader indices during a choppy market. Here's what worked and why.

Methodology Note

Before diving in, a quick note on how we measure performance:

  • We track the top 5 stocks identified by each premise at the time of the query
  • Returns are calculated from query date through end of quarter
  • We compare against the S&P 500 as a baseline
  • This is historical analysis, not a guarantee of future performance

The S&P 500 returned 2.3% in Q3 2025. Here are the premises that beat it.

1. Grid-Scale Energy Storage (+41.2%)

The Premise: "Companies manufacturing or deploying utility-scale battery storage systems"

Why It Worked:

The Inflation Reduction Act's battery manufacturing credits finally started flowing in earnest. Combined with record solar installations requiring storage for grid stability, demand for battery systems exceeded even bullish forecasts.

Top Performers:

  • Fluence Energy (FLNC): +67% — Won massive contracts with PG&E and Duke Energy
  • Stem Inc (STEM): +44% — Software-driven storage optimization gained traction
  • Eos Energy (EOSE): +38% — Zinc-based batteries found niche in long-duration storage

The Lesson: Sometimes the best opportunities aren't in the headline technology (solar, EVs) but in the enabling infrastructure required to make it work.

2. Defense Technology Modernization (+34.8%)

The Premise: "Defense contractors focused on autonomous systems, AI, and software-defined warfare"

Why It Worked:

The Pentagon's budget allocation shifted dramatically toward next-generation capabilities. Traditional hardware programs got cut; software and autonomy got funded. Companies positioned at this intersection benefited enormously.

Top Performers:

  • Palantir (PLTR): +52% — Army contract expansion; Maven successor programs
  • Anduril Industries (private, but worth watching): Valuation reportedly doubled
  • Kratos Defense (KTOS): +41% — Drone target and tactical UAV programs accelerated

The Lesson: Within any sector, there are winners and losers. "Defense stocks" is too broad—the premise that specified modernization captured the right subset.

3. Nuclear Renaissance (+29.4%)

The Premise: "Companies involved in nuclear power generation, uranium mining, or SMR development"

Why It Worked:

AI data center power demands made the energy math undeniable: you can't run 24/7 compute on intermittent renewables alone. Microsoft, Google, and Amazon all announced nuclear power agreements. Uranium prices broke out to 15-year highs.

Top Performers:

  • Cameco (CCJ): +36% — Largest pure-play uranium producer
  • Constellation Energy (CEG): +31% — Largest US nuclear fleet operator
  • NuScale Power (SMR): +24% — Small modular reactor leader, despite no revenue

The Lesson: Narrative shifts matter. Nuclear went from "uninvestable" to "essential" in 18 months. Premise-based research caught the turn.

4. Japanese Corporate Restructuring (+26.1%)

The Premise: "Japanese companies unwinding cross-shareholdings and improving capital allocation"

Why It Worked:

Tokyo Stock Exchange pressure on companies trading below book value forced action. Buybacks hit record levels. Activist investors (both domestic and foreign) found receptive targets. The weak yen provided additional tailwinds for exporters.

Top Performers:

  • Toyota (TM): +29% — Massive buyback program; unwound legacy holdings
  • Hitachi (HTHIY): +27% — Continued portfolio rationalization
  • Mitsubishi Corp (MSBHF): +24% — Benefited from Berkshire's endorsement effect

The Lesson: Geographic and structural premises can be powerful. "Japanese restructuring" is more specific than "international stocks" and captures a real catalyst.

5. Weight Loss Drug Supply Chain (+23.7%)

The Premise: "Companies supplying manufacturing capacity, delivery devices, or active ingredients for GLP-1 drugs"

Why It Worked:

Everyone knows Novo Nordisk and Eli Lilly. But the supply chain? Contract manufacturers and specialty ingredient suppliers operated in relative obscurity—until capacity constraints made them critical.

Top Performers:

  • Catalent (CTLT): +31% — Fill-finish capacity at premium
  • Gerresheimer (GRRRF): +28% — Injection pen manufacturing
  • Bachem (BCHMF): +19% — Peptide synthesis expertise

The Lesson: Second-derivative plays often outperform. The "picks and shovels" approach works when primary beneficiaries are already priced for perfection.

6. Insurance Hardening (+19.8%)

The Premise: "Property and casualty insurers benefiting from premium rate increases"

Why It Worked:

After years of catastrophe losses and inflation, insurers finally achieved pricing power. Combined ratios improved. Investment income rose with higher rates. It was a textbook hard market cycle.

Top Performers:

  • Kinsale Capital (KNSL): +26% — E&S specialist with disciplined underwriting
  • RenaissanceRe (RNR): +21% — Reinsurance pricing inflected higher
  • W.R. Berkley (WRB): +18% — Diversified specialty insurer

The Lesson: Cyclical industries have predictable patterns. When the cycle turns, being positioned early creates outperformance.

7. Data Center Infrastructure REITs (+17.4%)

The Premise: "REITs with data center exposure in power-constrained markets"

Why It Worked:

AI compute demand created genuine scarcity. Northern Virginia, the world's largest data center market, essentially ran out of power. Landlords with existing capacity in constrained markets had pricing leverage they'd never seen before.

Top Performers:

  • Digital Realty (DLR): +22% — Portfolio in key constrained markets
  • Equinix (EQIX): +18% — Interconnection premium widened
  • VNET Group (VNET): +14% — China data center exposure rebounded

The Lesson: Specificity wins. "Data center REITs" was fine; "data center REITs in power-constrained markets" was better.

What Didn't Work

For balance, some premises that underperformed:

  • "Electric vehicle pure-plays" (-12%): Competition intensified; Tesla's margin compression spread industry-wide
  • "Regional banks with commercial real estate exposure" (-8%): Office distress continued longer than expected
  • "Chinese consumer recovery plays" (-6%): Stimulus disappointed; deflation concerns persisted

Implications for Q4

Looking ahead, several themes from Q3 appear durable:

  • Power constraints remain binding for AI infrastructure
  • Defense modernization is a multi-year cycle
  • GLP-1 capacity won't catch up to demand until late 2026

The question is whether valuations have already adjusted. Premise-based research is most valuable when it identifies themes before consensus recognizes them.

That's the challenge for Q4: finding the next unpriced insight.